Silvia Damian

Fondazione IRCCS Istituto Nazionale dei Tumori

Emailsilvia.damian@istitutotumori.mi.it

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Silvia Damian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

0 Similar Profiles

letrozole Medicine & Life Sciences

Breast Neoplasms Medicine & Life Sciences

Paclitaxel Medicine & Life Sciences

Anthracyclines Medicine & Life Sciences

Safety Medicine & Life Sciences

Salivary Glands Medicine & Life Sciences

L-Lactate Dehydrogenase Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

6 Article

Combination of baseline LDH, performance status and age as integrated algorithm to identify solid tumor patients with higher probability of response to anti PD-1 and PD-l1 monoclonal antibodies

Cona, M. S., Lecchi, M., Cresta, S., Damian, S., Del Vecchio, M., Necchi, A., Poggi, M. M., Raggi, D., Randon, G., Ratta, R., Signorelli, D., Vernieri, C., de Braud, F., Verderio, P. & Di Nicola, M., Feb 2019, In : Cancers. 11, 2, 223.

Research output: Contribution to journal › Article

Open Access

L-Lactate Dehydrogenase

Monoclonal Antibodies

CD274 Antigen

Area Under Curve

Neoplasms

Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study

Mariani, G., Galli, G., Cavalieri, S., Valagussa, P., Bianchi, G. V., Capri, G., Cresta, S., Ferrari, L., Damian, S., Duca, M., de Braud, F. & Moliterni, A., Mar 1 2019, In : Breast Journal. 25, 2, p. 237-242 6 p.

Research output: Contribution to journal › Article

Anthracyclines

Breast Neoplasms

Drug Therapy

Paclitaxel

Methotrexate

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer

Schöffski, P., Cresta, S., Mayer, I. A., Wildiers, H., Damian, S., Gendreau, S., Rooney, I., Morrissey, K. M., Spoerke, J. M., Ng, V. W., Singel, S. M. & Winer, E., Sep 5 2018, In : Breast Cancer Research. 20, 1, p. 109

Research output: Contribution to journal › Article

letrozole

Paclitaxel

Breast Neoplasms

Maximum Tolerated Dose

Phosphatidylinositol 3-Kinase

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study

Cohen, R. B., Delord, J-P., Doi, T., Piha-Paul, S. A., Liu, S. V., Gilbert, J., Algazi, A. P., Damian, S., Hong, R-L., Le Tourneau, C., Day, D., Varga, A., Elez, E., Wallmark, J., Saraf, S., Thanigaimani, P., Cheng, J. & Keam, B., Feb 21 2018, In : American Journal of Clinical Oncology.

Research output: Contribution to journal › Article

Salivary Glands

Carcinoma

Ligands

Therapeutics

Licensure

Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1)

Drilon, A., Siena, S., Ou, S. H. I., Patel, M., Ahn, M. J., Lee, J., Bauer, T. M., Farago, A. F., Wheler, J. J., Liu, S. V., Doebele, R., Giannetta, L., Cerea, G., Marrapese, G., Schirru, M., Amatu, A., Bencardino, K., Palmeri, L., Sartore-Bianchi, A., Vanzulli, A. & 15 others, Cresta, S., Damian, S., Duca, M., Ardini, E., Li, G., Christiansen, J., Kowalski, K., Johnson, A. D., Patel, R., Luo, D., Chow-Maneval, E., Hornby, Z., Multani, P. S., Shaw, A. T. & De Braud, F. G., Apr 1 2017, In : Cancer Discovery. 7, 4, p. 400-409 10 p.

Research output: Contribution to journal › Article

Gene Fusion

Safety

Central Nervous System Diseases

Neoplasms

Gene Targeting